<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04288167</url>
  </required_header>
  <id_info>
    <org_study_id>T257/2019</org_study_id>
    <nct_id>NCT04288167</nct_id>
  </id_info>
  <brief_title>Biochemical Diagnostics of Mild Traumatic Brain Injury (TBI) and Concussion in Children and Adolescents</brief_title>
  <official_title>Biochemical Diagnostics of Mild Traumatic Brain Injury (TBI) and Concussion in Children and Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicortex Finland Oy</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Satasairaala</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medicortex Finland Oy</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will enroll children and adolescents (0 - 17 years) suspected of having concussion&#xD;
      or mild traumatic brain injury (TBI). Samples of urine and saliva will be collected from the&#xD;
      patients as well as from corresponding age- and gender-adjusted healthy controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The collected samples will be alienated to the Sponsor who will perform biochemical studies&#xD;
      to identify and measure from the samples relative level of the brain injury-specific&#xD;
      biomarkers.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 14, 2020</start_date>
  <completion_date type="Actual">April 14, 2021</completion_date>
  <primary_completion_date type="Actual">April 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>The laboratories will analyze the samples blinded, without knowing whether the sample was from an injured patient or a healthy control.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker levels</measure>
    <time_frame>12 months</time_frame>
    <description>Quantitative measurement of the novel glycan-based biomarker using a lectin-binding assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomarker profiles</measure>
    <time_frame>12 months</time_frame>
    <description>Characterization of different glycan structures present in the sample by mass spectrometry analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Brain Injuries, Traumatic</condition>
  <arm_group>
    <arm_group_label>Patients with suspected brain injury</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will consist of up to 30 pediatric patients who entered the Emergency Room and who are suspected of having mild traumatic brain injury. Two sample sets will be collected within the first 10 hours from the injury.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm will consist of up to 30 healthy control subjects, the samples of whom will be compared to the samples of brain injury patients (Arm 1). One sample set will be collected from healthy children without any known brain injury.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Sample collection</intervention_name>
    <description>Samples of urine and saliva will be collected from participants using customary sample collection means.</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>Patients with suspected brain injury</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The subject is suspected of having an isolated mild TBI (Glasgow Coma Score 13 - 15)&#xD;
&#xD;
          -  No more that 6 hours elapsed from the incident of injury at the first sampling&#xD;
&#xD;
          -  The patient is conscious&#xD;
&#xD;
          -  Informed consent received from the legal guardian, and the subject him-/herself when&#xD;
             literate and capable of understanding study measures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than 6 hours elapsed from the injury, or unknown time of trauma&#xD;
&#xD;
          -  Multi-trauma patient&#xD;
&#xD;
          -  History of head injury, seizures or stroke within three preceding months&#xD;
&#xD;
          -  Chronic neurodegenerative, metabolic or autoimmune disease&#xD;
&#xD;
          -  Known existing neurological condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sari Malmi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Satasairaala</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Satakunta Central Hospital</name>
      <address>
        <city>Pori</city>
        <zip>28500</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 13, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 28, 2020</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Brain Concussion</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data shall not be shared to outside of the study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

